(-)-demecolcine increases expression EXP 6480464 Demecolcine results in increased expression of BIRC3 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of BIRC3 mRNA CTD PMID:22079256 (aminomethyl)phosphonic acid multiple interactions EXP 6480464 [1-aminomethylphosphonic acid co-treated with methoxyacetic acid] results in decreased expression of BIRC3 protein CTD PMID:26006246 1'-acetoxychavicol acetate multiple interactions EXP 6480464 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of BIRC3 protein] CTD PMID:15905586 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:621282 6480464 o, p'-DDT analog results in increased expression of BIRC3 mRNA CTD PMID:22937105 1,2-dichloroethane decreases expression ISO RGD:733266 6480464 ethylene dichloride results in decreased expression of BIRC3 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:733266 6480464 1, 2-Dimethylhydrazine results in decreased expression of BIRC3 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression ISO RGD:621282 6480464 1-Naphthylisothiocyanate results in decreased expression of BIRC3 mRNA CTD PMID:25380136 1-naphthyl isothiocyanate increases expression ISO RGD:621282 6480464 1-Naphthylisothiocyanate results in increased expression of BIRC3 mRNA CTD PMID:30723492 1-nitropyrene increases expression EXP 6480464 1-nitropyrene results in increased expression of BIRC3 mRNA CTD PMID:21540303 15-deoxy-Delta(12,14)-prostaglandin J2 decreases expression EXP 6480464 15-deoxy-delta12, 14-prostaglandin J2 results in decreased expression of BIRC3 protein CTD PMID:15498850 17alpha-ethynylestradiol multiple interactions ISO RGD:733266 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BIRC3 mRNA, Ethinyl Estradiol inhibits the reaction [IL1B protein results in increased expression of BIRC3 mRNA] CTD PMID:12072388 , PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:621282 6480464 Ethinyl Estradiol results in increased expression of BIRC3 mRNA CTD PMID:17557909 17alpha-ethynylestradiol increases expression ISO RGD:733266 6480464 Ethinyl Estradiol results in increased expression of BIRC3 mRNA CTD PMID:17942748 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of BIRC3 mRNA CTD PMID:14699072 17beta-estradiol multiple interactions ISO RGD:621282 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BIRC3 mRNA CTD PMID:32741896 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of BIRC3 mRNA CTD PMID:20106945 , PMID:23373633 17beta-estradiol multiple interactions EXP 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of BIRC3 mRNA more ... CTD PMID:20404318 more ... 17beta-estradiol 3-benzoate multiple interactions ISO RGD:621282 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BIRC3 mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:733266 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:733266 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:621282 6480464 Tetrachlorodibenzodioxin results in increased expression of BIRC3 mRNA CTD PMID:19520675 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BIRC3 mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733266 6480464 Tetrachlorodibenzodioxin affects the expression of BIRC3 mRNA CTD PMID:21570461 , PMID:31776611 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:621282 6480464 Tetrachlorodibenzodioxin affects the expression of BIRC3 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733266 6480464 Tetrachlorodibenzodioxin results in increased expression of BIRC3 mRNA CTD PMID:12167310 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733266 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BIRC3 mRNA CTD PMID:17942748 2,4-dinitrotoluene affects expression ISO RGD:621282 6480464 2, 4-dinitrotoluene affects the expression of BIRC3 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression ISO RGD:621282 6480464 2, 6-dinitrotoluene affects the expression of BIRC3 mRNA CTD PMID:21346803 2-butoxyethanol decreases expression ISO RGD:733266 6480464 n-butoxyethanol results in decreased expression of BIRC3 mRNA CTD PMID:19812364 2-hydroxypropanoic acid increases expression EXP 6480464 Lactic Acid results in increased expression of BIRC3 mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:621282 6480464 tetrabromobisphenol A results in increased expression of BIRC3 mRNA CTD PMID:28970181 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of BIRC3 mRNA CTD PMID:28070108 3-iodobenzyl-5'-N-methylcarboxamidoadenosine decreases expression EXP 6480464 N6-3-iodobenzyl-5'-N-methylcarboxamidoadenosine results in decreased expression of BIRC3 mRNA CTD PMID:16088125 3-iodobenzyl-5'-N-methylcarboxamidoadenosine decreases response to substance EXP 6480464 BIRC3 protein results in decreased susceptibility to N6-3-iodobenzyl-5'-N-methylcarboxamidoadenosine CTD PMID:16088125 3-methylcholanthrene increases expression ISO RGD:733266 6480464 Methylcholanthrene results in increased expression of BIRC3 mRNA CTD PMID:29554273 3-phenylprop-2-enal multiple interactions EXP 6480464 Vitamin E inhibits the reaction [cinnamic aldehyde results in decreased expression of BIRC3 protein] CTD PMID:15566391 3-phenylprop-2-enal decreases expression EXP 6480464 cinnamic aldehyde results in decreased expression of BIRC3 protein CTD PMID:15566391 4,4'-diaminodiphenylmethane decreases expression ISO RGD:621282 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of BIRC3 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO RGD:733266 6480464 bis4-hydroxyphenylsulfone results in increased expression of BIRC3 mRNA CTD PMID:30951980 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-N-methyl-N-nitrosamino-1-3-pyridyl-1-butanone results in increased expression of BIRC3 protein CTD PMID:18508827 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions EXP 6480464 SN50 peptide inhibits the reaction [4-N-methyl-N-nitrosamino-1-3-pyridyl-1-butanone results in increased expression of BIRC3 protein] more ... CTD PMID:18508827 4-aminopyridine decreases expression ISO RGD:621282 6480464 4-Aminopyridine results in decreased expression of BIRC3 mRNA CTD PMID:24378259 4-hydroxyphenyl retinamide increases expression ISO RGD:733266 6480464 Fenretinide results in increased expression of BIRC3 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression EXP 6480464 Decitabine affects the expression of BIRC3 protein CTD PMID:18636160 5-fluorouracil increases expression EXP 6480464 Fluorouracil results in increased expression of BIRC3 mRNA CTD PMID:16557594 6-propyl-2-thiouracil decreases expression ISO RGD:621282 6480464 Propylthiouracil results in decreased expression of BIRC3 mRNA CTD PMID:25825206 acetamide increases expression ISO RGD:621282 6480464 acetamide results in increased expression of BIRC3 mRNA CTD PMID:31881176 acrolein multiple interactions EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased expression of BIRC3 protein] more ... CTD PMID:19596284 acrolein increases expression EXP 6480464 Acrolein results in increased expression of BIRC3 protein CTD PMID:19596284 actinomycin D multiple interactions EXP 6480464 BIRC3 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] CTD PMID:11880364 adenosine decreases expression EXP 6480464 Adenosine results in decreased expression of BIRC3 mRNA CTD PMID:20063052 aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of BIRC3 protein CTD PMID:20106945 aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of BIRC3 exon CTD PMID:30157460 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of BIRC3 mRNA CTD PMID:27153756 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of BIRC3 mRNA, Tretinoin results in decreased expression of BIRC3 protein CTD PMID:17701358 more ... all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of BIRC3 mRNA CTD PMID:23830798 all-trans-retinoic acid multiple interactions EXP 6480464 [Tretinoin co-treated with Paclitaxel] results in decreased expression of BIRC3 protein CTD PMID:17701358 , PMID:18098270 alvocidib decreases expression EXP 6480464 alvocidib results in decreased expression of BIRC3 mRNA, alvocidib results in decreased expression of BIRC3 protein CTD PMID:12517783 alvocidib multiple interactions EXP 6480464 Epothilones promotes the reaction [alvocidib results in decreased expression of BIRC3 mRNA], Epothilones promotes the reaction [alvocidib results in decreased expression of BIRC3 protein] CTD PMID:12517783 ammonium chloride affects expression ISO RGD:621282 6480464 Ammonium Chloride affects the expression of BIRC3 mRNA CTD PMID:16483693 Anacardic acid multiple interactions EXP 6480464 anacardic acid inhibits the reaction [TNF protein results in increased expression of BIRC3 protein] CTD PMID:18349320 antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of BIRC3 mRNA CTD PMID:24449571 apigenin increases cleavage EXP 6480464 Apigenin results in increased cleavage of BIRC3 protein CTD PMID:15486995 apigenin multiple interactions EXP 6480464 [TNFSF10 protein results in increased susceptibility to Apigenin] which results in decreased expression of BIRC3 protein CTD PMID:29247770 aprepitant decreases expression EXP 6480464 Aprepitant results in decreased expression of BIRC3 mRNA CTD PMID:30145367 aprepitant multiple interactions EXP 6480464 Arsenic Trioxide promotes the reaction [Aprepitant results in decreased expression of BIRC3 mRNA] CTD PMID:30145367 arsane multiple interactions EXP 6480464 [Arsenic co-treated with Fluorides] results in decreased expression of BIRC3 mRNA CTD PMID:19962721 arsenic atom multiple interactions EXP 6480464 [Arsenic co-treated with Fluorides] results in decreased expression of BIRC3 mRNA CTD PMID:19962721 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of BIRC3 mRNA CTD PMID:24356939 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BIRC3 mRNA, Arsenic Trioxide results in decreased expression of BIRC3 protein CTD PMID:19763917 more ... arsenous acid multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Curcumin] results in decreased expression of BIRC3 protein more ... CTD PMID:27430728 more ... beauvericin increases expression EXP 6480464 beauvericin results in increased expression of BIRC3 mRNA CTD PMID:29203277 benzene increases expression EXP 6480464 Benzene results in increased expression of BIRC3 mRNA CTD PMID:20359517 benzene-1,2,4-triol multiple interactions EXP 6480464 4-aminobenzhydrazide inhibits the reaction [hydroxyhydroquinone results in increased expression of BIRC3 mRNA] CTD PMID:24530881 benzene-1,2,4-triol increases expression EXP 6480464 hydroxyhydroquinone results in increased expression of BIRC3 mRNA CTD PMID:24530881 benzo[a]pyrene affects expression EXP 6480464 Benzoapyrene affects the expression of BIRC3 mRNA CTD PMID:21873647 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of BIRC3 mRNA CTD PMID:20064835 more ... benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene metabolite results in decreased expression of BIRC3 mRNA, Benzoapyrene results in decreased expression of BIRC3 mRNA CTD PMID:16120219 , PMID:24356939 benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of BIRC3 mRNA CTD PMID:32151702 bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of BIRC3 mRNA CTD PMID:25102026 bisphenol A increases expression ISO RGD:621282 6480464 bisphenol A results in increased expression of BIRC3 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:733266 6480464 bisphenol A results in increased expression of BIRC3 mRNA CTD PMID:30951980 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of BIRC3 mRNA CTD PMID:29275510 bisphenol A increases methylation ISO RGD:621282 6480464 bisphenol A results in increased methylation of BIRC3 gene CTD PMID:28505145 bisphenol F increases expression ISO RGD:733266 6480464 bisphenol F results in increased expression of BIRC3 mRNA CTD PMID:30951980 bortezomib decreases expression EXP 6480464 Bortezomib results in decreased expression of BIRC3 protein CTD PMID:17626072 bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of BIRC3 mRNA, Bortezomib results in increased expression of BIRC3 protein CTD PMID:24085292 bortezomib multiple interactions EXP 6480464 [BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in increased expression of BIRC3 mRNA CTD PMID:25522274 bryostatin 1 increases expression EXP 6480464 bryostatin 1 results in increased expression of BIRC3 mRNA CTD PMID:14527959 butanal increases expression EXP 6480464 butyraldehyde results in increased expression of BIRC3 mRNA CTD PMID:26079696 cadmium atom decreases expression ISO RGD:621282 6480464 Cadmium results in decreased expression of BIRC3 protein CTD PMID:16478757 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of BIRC3 mRNA CTD PMID:22562489 cadmium dichloride decreases expression ISO RGD:621282 6480464 Cadmium Chloride results in decreased expression of BIRC3 protein CTD PMID:16478757 calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of BIRC3 mRNA CTD PMID:21592394 calcitriol multiple interactions EXP 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of BIRC3 mRNA CTD PMID:21592394 calcitriol decreases expression EXP 6480464 Calcitriol results in decreased expression of BIRC3 mRNA, Calcitriol results in decreased expression of BIRC3 protein CTD PMID:12479363 , PMID:16002434 carbon monoxide multiple interactions EXP 6480464 BIRC3 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]], MAPK14 protein affects the reaction [BIRC3 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]] CTD PMID:11880364 carbon nanotube affects expression ISO RGD:733266 6480464 Nanotubes, Carbon analog affects the expression of BIRC3 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:733266 6480464 Nanotubes, Carbon results in decreased expression of BIRC3 mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:733266 6480464 Nanotubes, Carbon results in increased expression of BIRC3 mRNA CTD PMID:25554681 cefaloridine increases expression ISO RGD:621282 6480464 Cephaloridine results in increased expression of BIRC3 mRNA CTD PMID:18500788 chrysazin increases expression EXP 6480464 danthron results in increased expression of BIRC3 protein CTD PMID:21126053 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of BIRC3 protein CTD PMID:16391810 cisplatin increases expression ISO RGD:733266 6480464 Cisplatin results in increased expression of BIRC3 mRNA CTD PMID:26546572 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of BIRC3 mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:733266 6480464 [Cisplatin co-treated with TNF protein] results in decreased expression of BIRC3 mRNA CTD PMID:23103562 cisplatin decreases response to substance EXP 6480464 BIRC3 protein results in decreased susceptibility to Cisplatin CTD PMID:14654915 cladribine multiple interactions EXP 6480464 Cladribine promotes the reaction [Bendamustine Hydrochloride results in decreased expression of BIRC3 protein] CTD PMID:12948851 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of BIRC3 protein CTD PMID:25125499 cobalt dichloride multiple interactions EXP 6480464 lysophosphatidylethanolamine analog inhibits the reaction [cobaltous chloride results in decreased expression of BIRC3 protein] CTD PMID:25125499 copper atom multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which affects the expression of BIRC3 mRNA CTD PMID:30911355 copper(0) multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which affects the expression of BIRC3 mRNA CTD PMID:30911355 copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of BIRC3 mRNA CTD PMID:19549813 crocidolite asbestos increases expression EXP 6480464 Asbestos, Crocidolite results in increased expression of BIRC3 mRNA CTD PMID:18687144 , PMID:25351596 crocidolite asbestos decreases expression EXP 6480464 Asbestos, Crocidolite results in decreased expression of BIRC3 mRNA CTD PMID:29523930 crocidolite asbestos affects expression EXP 6480464 Asbestos, Crocidolite affects the expression of BIRC3 mRNA CTD PMID:25757056 crotonaldehyde multiple interactions EXP 6480464 [2-butenal co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BIRC3 mRNA CTD PMID:24849683 cryptolepine decreases expression EXP 6480464 cryptolepine results in decreased expression of BIRC3 mRNA CTD PMID:16120219 curcumin multiple interactions EXP 6480464 [arsenic trioxide co-treated with Curcumin] results in decreased expression of BIRC3 protein more ... CTD PMID:15911101 more ... curcumin multiple interactions ISO RGD:733266 6480464 [Curcumin co-treated with gemcitabine] results in decreased expression of BIRC3 protein CTD PMID:17440100 curcumin increases expression EXP 6480464 Curcumin results in increased expression of BIRC3 mRNA CTD PMID:15911101 , PMID:16101141 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of BIRC3 mRNA, Curcumin results in decreased expression of BIRC3 protein CTD PMID:17596214 more ... cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide metabolite results in decreased expression of BIRC3 mRNA CTD PMID:24356939 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of BIRC3 mRNA CTD PMID:20106945 , PMID:27989131 cyclosporin A increases expression ISO RGD:621282 6480464 Cyclosporine results in increased expression of BIRC3 mRNA CTD PMID:21865292 dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [TNF protein results in decreased expression of BIRC3 protein] CTD PMID:11399663 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of BIRC3 mRNA, Dexamethasone results in increased expression of BIRC3 protein CTD PMID:12782123 more ... dexamethasone increases expression ISO RGD:621282 6480464 Dexamethasone results in increased expression of BIRC3 mRNA CTD PMID:20032058 dexamethasone multiple interactions ISO RGD:621282 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of BIRC3 mRNA] CTD PMID:20032058 diallyl disulfide decreases expression EXP 6480464 diallyl disulfide results in decreased expression of BIRC3 protein CTD PMID:17647244 Diallyl sulfide decreases expression EXP 6480464 allyl sulfide results in decreased expression of BIRC3 protein CTD PMID:17647244 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BIRC3 mRNA, Arsenic Trioxide results in decreased expression of BIRC3 protein CTD PMID:19763917 more ... diarsenic trioxide multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Curcumin] results in decreased expression of BIRC3 protein more ... CTD PMID:27430728 more ... diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of BIRC3 mRNA CTD PMID:24356939 dichloromethane increases expression EXP 6480464 Methylene Chloride results in increased expression of BIRC3 mRNA CTD PMID:20359517 dicrotophos decreases expression EXP 6480464 dicrotophos results in decreased expression of BIRC3 mRNA CTD PMID:28302478 dieldrin affects expression ISO RGD:621282 6480464 Dieldrin affects the expression of BIRC3 mRNA CTD PMID:22546817 diethyl maleate multiple interactions ISO RGD:733266 6480464 diethyl maleate inhibits the reaction [TNF protein results in increased expression of BIRC3 mRNA] CTD PMID:12774022 dioxygen multiple interactions EXP 6480464 [Rotenone co-treated with Thenoyltrifluoroacetone] inhibits the reaction [Oxygen deficiency results in increased expression of BIRC3 mRNA], AG 1879 inhibits the reaction [Oxygen deficiency results in increased expression of BIRC3 mRNA] CTD PMID:17671207 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of BIRC3 mRNA CTD PMID:17671207 disodium selenite decreases expression EXP 6480464 Sodium Selenite results in decreased expression of BIRC3 mRNA CTD PMID:16705456 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 doxorubicin decreases response to substance EXP 6480464 BIRC3 protein results in decreased susceptibility to Doxorubicin CTD PMID:12926068 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of BIRC3 mRNA CTD PMID:15899819 , PMID:29803840 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of BIRC3 mRNA CTD PMID:16705698 , PMID:17521628 doxorubicin affects response to substance EXP 6480464 BIRC3 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin multiple interactions EXP 6480464 [Curcumin co-treated with Doxorubicin] affects the expression of BIRC3 mRNA more ... CTD PMID:15899819 , PMID:15911101 endosulfan decreases expression ISO RGD:621282 6480464 Endosulfan results in decreased expression of BIRC3 mRNA CTD PMID:29391264 entinostat increases expression EXP 6480464 entinostat results in increased expression of BIRC3 mRNA CTD PMID:27188386 ethanol multiple interactions EXP 6480464 Ethanol inhibits the reaction [FOXO3 protein results in increased expression of BIRC3 mRNA] CTD PMID:26470730 ethylbenzene increases expression EXP 6480464 ethylbenzene results in increased expression of BIRC3 mRNA CTD PMID:20359517 etoposide decreases response to substance EXP 6480464 BIRC3 protein results in decreased susceptibility to Etoposide CTD PMID:15050749 etoposide decreases expression EXP 6480464 Etoposide results in decreased expression of BIRC3 mRNA CTD PMID:16120219 etoposide multiple interactions EXP 6480464 [Etoposide co-treated with KN 62] results in decreased expression of BIRC3 protein CTD PMID:14666661 Evodiamine multiple interactions EXP 6480464 evodiamine inhibits the reaction [TNF protein results in increased expression of BIRC3 protein] CTD PMID:15710601 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of BIRC3 mRNA CTD PMID:20520642 fluoranthene multiple interactions ISO RGD:733266 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of BIRC3 mRNA CTD PMID:28329830 flutamide multiple interactions ISO RGD:733266 6480464 [CBL protein affects the susceptibility to Flutamide] which affects the expression of BIRC3 mRNA, [CBL protein affects the susceptibility to Flutamide] which affects the expression of BIRC3 protein CTD PMID:16301331 folic acid affects expression EXP 6480464 Folic Acid affects the expression of BIRC3 mRNA CTD PMID:16361273 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of BIRC3 mRNA CTD PMID:21867686 folic acid multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of BIRC3 mRNA CTD PMID:24657277 furan increases expression ISO RGD:621282 6480464 furan results in increased expression of BIRC3 mRNA CTD PMID:20562052 , PMID:22079235 gamma-aminobutyric acid decreases expression ISO RGD:621282 6480464 gamma-Aminobutyric Acid results in decreased expression of BIRC3 mRNA CTD PMID:26924987 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of BIRC3 mRNA CTD PMID:24356939 gastrin-17 multiple interactions EXP 6480464 [gastrin 17 co-treated with CCKBR protein] results in decreased expression of BIRC3 CTD PMID:17704804 gemcitabine affects expression EXP 6480464 gemcitabine affects the expression of BIRC3 mRNA CTD PMID:17039268 gemcitabine multiple interactions ISO RGD:733266 6480464 [Curcumin co-treated with gemcitabine] results in decreased expression of BIRC3 protein CTD PMID:17440100 Genipin multiple interactions ISO RGD:733266 6480464 genipin inhibits the reaction [Lipopolysaccharides results in increased expression of BIRC3 mRNA] CTD PMID:22687549 gliotoxin multiple interactions EXP 6480464 Gliotoxin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BIRC3 mRNA] CTD PMID:14527959 glutathione multiple interactions EXP 6480464 Glutathione inhibits the reaction [Thimerosal results in decreased expression of BIRC3 protein] CTD PMID:12140745 gold atom decreases expression EXP 6480464 Gold results in decreased expression of BIRC3 mRNA CTD PMID:25523186 gold(0) decreases expression EXP 6480464 Gold results in decreased expression of BIRC3 mRNA CTD PMID:25523186 graphite affects expression ISO RGD:621282 6480464 Graphite affects the expression of BIRC3 mRNA CTD PMID:29933104 homocysteine decreases expression EXP 6480464 Homocysteine results in decreased expression of BIRC3 mRNA, Homocysteine results in decreased expression of BIRC3 protein CTD PMID:19343037 homocysteine multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Homocysteine results in decreased expression of BIRC3 mRNA], Simvastatin inhibits the reaction [Homocysteine results in decreased expression of BIRC3 protein] CTD PMID:19343037 hydroquinone increases expression EXP 6480464 hydroquinone results in increased expression of BIRC3 mRNA CTD PMID:15452088 hydroquinone decreases expression EXP 6480464 hydroquinone results in decreased expression of BIRC3 mRNA CTD PMID:31256213 ibrutinib decreases expression EXP 6480464 ibrutinib results in decreased expression of BIRC3 mRNA CTD PMID:26254443 indole-3-methanol multiple interactions EXP 6480464 indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BIRC3 protein] CTD PMID:15811958 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of BIRC3 mRNA CTD PMID:16984733 indometacin multiple interactions EXP 6480464 Indomethacin inhibits the reaction [LTA protein results in increased expression of BIRC3 protein] CTD PMID:17873517 irinotecan affects expression ISO RGD:621282 6480464 Irinotecan affects the expression of BIRC3 mRNA CTD PMID:20097248 isoflurane decreases expression ISO RGD:621282 6480464 Isoflurane results in decreased expression of BIRC3 mRNA CTD PMID:16978161 isoliquiritigenin decreases expression EXP 6480464 isoliquiritigenin results in decreased expression of BIRC3 protein CTD PMID:15729620 L-ascorbic acid multiple interactions EXP 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of BIRC3 mRNA CTD PMID:17639512 lead diacetate decreases expression ISO RGD:733266 6480464 lead acetate results in decreased expression of BIRC3 mRNA CTD PMID:21829687 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of BIRC3 mRNA CTD PMID:28988120 leptomycin B affects localization EXP 6480464 leptomycin B affects the localization of BIRC3 protein CTD PMID:15265700 linalool increases expression EXP 6480464 linalool results in increased expression of BIRC3 mRNA CTD PMID:19922762 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of BIRC3 mRNA, Lipopolysaccharides results in increased expression of BIRC3 protein CTD PMID:15454145 lipopolysaccharide multiple interactions ISO RGD:733266 6480464 genipin inhibits the reaction [Lipopolysaccharides results in increased expression of BIRC3 mRNA] CTD PMID:22687549 lipopolysaccharide increases expression ISO RGD:733266 6480464 Lipopolysaccharides results in increased expression of BIRC3 mRNA CTD PMID:22687549 lonafarnib multiple interactions EXP 6480464 lonafarnib inhibits the reaction [TNF protein results in increased expression of BIRC3 protein] CTD PMID:15090542 LY294002 decreases expression EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of BIRC3 protein CTD PMID:12970779 , PMID:14762343 LY294002 multiple interactions EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased expression of BIRC3 protein] more ... CTD PMID:15339911 , PMID:19596284 lysophosphatidylethanolamine multiple interactions EXP 6480464 lysophosphatidylethanolamine analog inhibits the reaction [cobaltous chloride results in decreased expression of BIRC3 protein] CTD PMID:25125499 melittin decreases expression EXP 6480464 Melitten results in decreased expression of BIRC3 protein CTD PMID:21456063 mercury atom increases expression EXP 6480464 Mercury results in increased expression of BIRC3 mRNA CTD PMID:16823088 mercury(0) increases expression EXP 6480464 Mercury results in increased expression of BIRC3 mRNA CTD PMID:16823088 methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of BIRC3 mRNA CTD PMID:21678067 , PMID:24657277 methotrexate multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of BIRC3 mRNA CTD PMID:24657277 methoxyacetic acid multiple interactions EXP 6480464 [1-aminomethylphosphonic acid co-treated with methoxyacetic acid] results in decreased expression of BIRC3 protein CTD PMID:26006246 methyl methanesulfonate decreases expression EXP 6480464 Methyl Methanesulfonate results in decreased expression of BIRC3 mRNA CTD PMID:23649840 methylparaben decreases expression EXP 6480464 methylparaben results in decreased expression of BIRC3 mRNA CTD PMID:31745603 methylseleninic acid affects expression EXP 6480464 methylselenic acid affects the expression of BIRC3 mRNA CTD PMID:14617803 microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of BIRC3 protein CTD PMID:22539157 Mitotane increases expression ISO RGD:621282 6480464 Mitotane results in increased expression of BIRC3 mRNA CTD PMID:23485034 morin decreases expression EXP 6480464 morin results in decreased expression of BIRC3 mRNA CTD PMID:28689916 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in decreased expression of BIRC3 protein] CTD PMID:19679660 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BIRC3 mRNA] CTD PMID:14527959 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of BIRC3 mRNA, benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of BIRC3 protein CTD PMID:24085292 N-nitrosodiethylamine multiple interactions ISO RGD:621282 6480464 [3 more ... CTD PMID:27048571 N-nitrosodimethylamine decreases expression ISO RGD:621282 6480464 Dimethylnitrosamine results in decreased expression of BIRC3 mRNA CTD PMID:25380136 N-tosyl-L-phenylalanyl chloromethyl ketone multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in decreased expression of BIRC3 protein] CTD PMID:19679660 N-tosyl-L-phenylalanyl chloromethyl ketone decreases expression EXP 6480464 Tosylphenylalanyl Chloromethyl Ketone results in decreased expression of BIRC3 protein CTD PMID:19679660 nickel atom increases expression EXP 6480464 Nickel results in increased expression of BIRC3 mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride increases expression EXP 6480464 nickel chloride results in increased expression of BIRC3 mRNA CTD PMID:17312168 nickel dichloride affects expression ISO RGD:621282 6480464 nickel chloride affects the expression of BIRC3 mRNA CTD PMID:22546817 nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of BIRC3 mRNA CTD PMID:16780908 nitric oxide increases expression ISO RGD:733266 6480464 Nitric Oxide results in increased expression of BIRC3 protein CTD PMID:14634119 nitric oxide decreases expression EXP 6480464 Nitric Oxide results in decreased expression of BIRC3 mRNA CTD PMID:15126337 o-xylene increases expression EXP 6480464 2-xylene results in increased expression of BIRC3 mRNA CTD PMID:20359517 obeticholic acid decreases expression EXP 6480464 obeticholic acid results in decreased expression of BIRC3 mRNA CTD PMID:27939613 ochratoxin A decreases expression EXP 6480464 ochratoxin A metabolite results in decreased expression of BIRC3 mRNA, ochratoxin A results in decreased expression of BIRC3 mRNA CTD PMID:24356939 , PMID:30763683 oxaliplatin multiple interactions ISO RGD:621282 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of BIRC3 mRNA CTD PMID:25729387 p-menthan-3-ol decreases expression EXP 6480464 Menthol results in decreased expression of BIRC3 mRNA CTD PMID:26760959 paclitaxel multiple interactions EXP 6480464 [Tretinoin co-treated with Paclitaxel] results in decreased expression of BIRC3 protein, Curcumin inhibits the reaction [Paclitaxel results in increased expression of BIRC3 protein] CTD PMID:16243823 more ... paclitaxel decreases expression EXP 6480464 Paclitaxel results in decreased expression of BIRC3 protein CTD PMID:14749477 more ... paracetamol affects expression ISO RGD:733266 6480464 Acetaminophen affects the expression of BIRC3 mRNA CTD PMID:17562736 paracetamol multiple interactions ISO RGD:733266 6480464 Acetaminophen inhibits the reaction [TNF protein results in increased expression of BIRC3 mRNA] CTD PMID:12774022 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of BIRC3 mRNA CTD PMID:18836921 PCB138 multiple interactions ISO RGD:733266 6480464 [2 more ... CTD PMID:25510870 PD 0325901 multiple interactions EXP 6480464 [+-JQ1 compound co-treated with PD 0325901] results in decreased expression of BIRC3 mRNA CTD PMID:25119042 pentanal increases expression EXP 6480464 pentanal results in increased expression of BIRC3 mRNA CTD PMID:26079696 Pentoxifylline multiple interactions EXP 6480464 [Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of BIRC3 protein CTD PMID:20804743 perfluorononanoic acid increases expression EXP 6480464 perfluorononanoic acid results in increased expression of BIRC3 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of BIRC3 mRNA CTD PMID:27153767 phenethyl caffeate decreases expression EXP 6480464 caffeic acid phenethyl ester results in decreased expression of BIRC3 protein CTD PMID:15291876 phenobarbital multiple interactions ISO RGD:621282 6480464 [3 more ... CTD PMID:27048571 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 [2-butenal co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BIRC3 mRNA more ... CTD PMID:14527959 , PMID:24849683 phorbol 13-acetate 12-myristate increases expression EXP 6480464 Tetradecanoylphorbol Acetate results in increased expression of BIRC3 mRNA CTD PMID:14527959 , PMID:31068361 pioglitazone decreases expression EXP 6480464 Pioglitazone results in decreased expression of BIRC3 mRNA CTD PMID:30031879 pirinixic acid decreases expression ISO RGD:733266 6480464 pirinixic acid results in decreased expression of BIRC3 mRNA CTD PMID:17426115 , PMID:23811191 potassium atom affects response to substance EXP 6480464 BIRC3 protein affects the susceptibility to Potassium CTD PMID:9886081 potassium chromate decreases expression EXP 6480464 potassium chromateVI results in decreased expression of BIRC3 mRNA CTD PMID:22079256 potassium chromate multiple interactions EXP 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of BIRC3 mRNA CTD PMID:22079256 progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in increased expression of BIRC3 mRNA CTD PMID:20660070 propanal increases expression EXP 6480464 propionaldehyde results in increased expression of BIRC3 mRNA CTD PMID:26079696 prostaglandin E2 increases expression EXP 6480464 Dinoprostone results in increased expression of BIRC3 protein CTD PMID:12837940 pyrrolidine dithiocarbamate multiple interactions EXP 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BIRC3 mRNA] CTD PMID:14527959 quercetin multiple interactions EXP 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of BIRC3 mRNA CTD PMID:17639512 rac-lactic acid increases expression EXP 6480464 Lactic Acid results in increased expression of BIRC3 mRNA CTD PMID:30851411 raloxifene multiple interactions EXP 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of BIRC3 mRNA CTD PMID:19059307 reactive oxygen species multiple interactions EXP 6480464 [Sulindac results in increased abundance of Reactive Oxygen Species] which results in decreased expression of BIRC3 protein CTD PMID:17136320 resveratrol multiple interactions EXP 6480464 BCL2 protein inhibits the reaction [resveratrol results in decreased expression of BIRC3 protein], resveratrol promotes the reaction [SIRT1 protein binds to BIRC3 promoter] CTD PMID:11577002 , PMID:15152190 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of BIRC3 protein CTD PMID:11577002 more ... rotenone multiple interactions EXP 6480464 [Rotenone co-treated with Thenoyltrifluoroacetone] inhibits the reaction [Oxygen deficiency results in increased expression of BIRC3 mRNA] CTD PMID:17671207 rottlerin multiple interactions EXP 6480464 rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BIRC3 mRNA] CTD PMID:14527959 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of BIRC3 mRNA more ... CTD PMID:22300531 more ... silicon dioxide multiple interactions EXP 6480464 [SULF1 mRNA results in increased susceptibility to Silicon Dioxide] which results in increased expression of BIRC3 mRNA CTD PMID:29673857 silicon dioxide increases expression ISO RGD:733266 6480464 Silicon Dioxide results in increased expression of BIRC3 mRNA CTD PMID:23221170 simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Homocysteine results in decreased expression of BIRC3 mRNA] more ... CTD PMID:17277159 , PMID:19343037 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of BIRC3 protein CTD PMID:12676792 sodium arsenite decreases methylation EXP 6480464 sodium arsenite results in decreased methylation of BIRC3 intron CTD PMID:32844245 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of BIRC3 mRNA CTD PMID:29301061 , PMID:32844245 sorafenib decreases expression EXP 6480464 sorafenib results in decreased expression of BIRC3 protein CTD PMID:20473320 staurosporine decreases response to substance EXP 6480464 BIRC3 protein results in decreased susceptibility to Staurosporine CTD PMID:16144937 succimer multiple interactions EXP 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BIRC3 mRNA CTD PMID:26378955 succimer multiple interactions ISO RGD:733266 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BIRC3 mRNA CTD PMID:26378955 sulindac multiple interactions EXP 6480464 [Sulindac results in increased abundance of Reactive Oxygen Species] which results in decreased expression of BIRC3 protein CTD PMID:17136320 sulindac sulfide increases expression EXP 6480464 sulindac sulfide results in increased expression of BIRC3 mRNA CTD PMID:16184548 tacrolimus hydrate increases expression ISO RGD:621282 6480464 Tacrolimus results in increased expression of BIRC3 mRNA CTD PMID:21865292 tamoxifen multiple interactions EXP 6480464 [Tamoxifen co-treated with ESR2 protein] results in increased expression of BIRC3 mRNA CTD PMID:19059307 Tanshinone I decreases expression EXP 6480464 tanshinone results in decreased expression of BIRC3 mRNA CTD PMID:15849732 tephrosin multiple interactions EXP 6480464 tephrosin inhibits the reaction [TNF protein results in increased expression of BIRC3 protein] CTD PMID:18841906 testosterone increases expression EXP 6480464 Testosterone results in increased expression of BIRC3 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:621282 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BIRC3 mRNA, Testosterone inhibits the reaction [Dexamethasone results in increased expression of BIRC3 mRNA] CTD PMID:20032058 , PMID:32741896 testosterone multiple interactions EXP 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of BIRC3 mRNA CTD PMID:21592394 thapsigargin multiple interactions EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Thapsigargin results in increased expression of BIRC3 mRNA], 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Thapsigargin results in increased expression of BIRC3 protein] CTD PMID:15339911 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of BIRC3 mRNA, Thapsigargin results in increased expression of BIRC3 protein CTD PMID:15339911 thimerosal multiple interactions EXP 6480464 Glutathione inhibits the reaction [Thimerosal results in decreased expression of BIRC3 protein] CTD PMID:12140745 thimerosal decreases expression EXP 6480464 Thimerosal results in decreased expression of BIRC3 protein CTD PMID:12140745 thioacetamide increases expression ISO RGD:621282 6480464 Thioacetamide results in increased expression of BIRC3 mRNA CTD PMID:23411599 titanium dioxide increases expression ISO RGD:733266 6480464 titanium dioxide results in increased expression of BIRC3 mRNA CTD PMID:23557971 , PMID:27760801 titanium dioxide increases expression ISO RGD:621282 6480464 titanium dioxide results in increased expression of BIRC3 mRNA CTD PMID:30012374 toluene increases expression EXP 6480464 Toluene results in increased expression of BIRC3 mRNA CTD PMID:20359517 topotecan multiple interactions ISO RGD:621282 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of BIRC3 mRNA CTD PMID:25729387 tributylstannane decreases expression EXP 6480464 tributyltin results in decreased expression of BIRC3 mRNA CTD PMID:27678064 Tributyltin oxide increases expression EXP 6480464 bistri-n-butyltinoxide results in increased expression of BIRC3 mRNA CTD PMID:24247028 Tributyltin oxide increases expression ISO RGD:621282 6480464 bistri-n-butyltinoxide results in increased expression of BIRC3 mRNA CTD PMID:17553608 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of BIRC3 mRNA CTD PMID:20359517 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of BIRC3 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A affects expression EXP 6480464 trichostatin A affects the expression of BIRC3 mRNA CTD PMID:28542535 trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of BIRC3 mRNA CTD PMID:27188386 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of BIRC3 mRNA CTD PMID:15972136 triptonide decreases expression ISO RGD:733266 6480464 triptonide results in decreased expression of BIRC3 mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:733266 6480464 troglitazone results in decreased expression of BIRC3 mRNA CTD PMID:17569031 trovafloxacin multiple interactions ISO RGD:733266 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of BIRC3 mRNA CTD PMID:18930950 trovafloxacin multiple interactions EXP 6480464 [trovafloxacin co-treated with TNF protein] results in increased expression of BIRC3 mRNA CTD PMID:32035082 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of BIRC3 mRNA CTD PMID:32035082 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of BIRC3 mRNA CTD PMID:25979313 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of BIRC3 mRNA CTD PMID:27188386 more ... vancomycin decreases expression ISO RGD:733266 6480464 Vancomycin results in decreased expression of BIRC3 mRNA CTD PMID:18930951 vincaleukoblastine affects response to substance EXP 6480464 BIRC3 protein affects the susceptibility to Vinblastine CTD PMID:16217747 vincristine increases expression EXP 6480464 Vincristine results in increased expression of BIRC3 mRNA CTD PMID:23649840 vitamin E multiple interactions EXP 6480464 Vitamin E inhibits the reaction [cinnamic aldehyde results in decreased expression of BIRC3 protein] CTD PMID:15566391 vorinostat multiple interactions EXP 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:16377638 more ... vorinostat increases expression EXP 6480464 vorinostat results in increased expression of BIRC3 mRNA CTD PMID:26272509 vorinostat decreases expression EXP 6480464 vorinostat results in decreased expression of BIRC3 protein CTD PMID:15897598 wortmannin multiple interactions EXP 6480464 wortmannin inhibits the reaction [Acrolein results in increased expression of BIRC3 protein] CTD PMID:19596284 zerumbone decreases expression EXP 6480464 zerumbone results in decreased expression of BIRC3 mRNA CTD PMID:16007145 zinc atom decreases expression EXP 6480464 Zinc results in decreased expression of BIRC3 protein CTD PMID:12429649 zinc protoporphyrin multiple interactions EXP 6480464 zinc protoporphyrin analog inhibits the reaction [4-N-methyl-N-nitrosamino-1-3-pyridyl-1-butanone results in increased expression of BIRC3 protein] CTD PMID:18508827 zinc(0) decreases expression EXP 6480464 Zinc results in decreased expression of BIRC3 protein CTD PMID:12429649 zoledronic acid increases expression EXP 6480464 zoledronic acid results in increased expression of BIRC3 mRNA CTD PMID:24714768
